Note: This is not an exhaustive list.
1. Gilead to acquire biotech company for $405M
Foster City, Calif.-based pharmaceutical company Gilead plans to purchase MiroBio, an Oxford, England-based biotech business, for $405 million in cash.
2. Amgen to acquire ChemoCentryx for $3.7B
Amgen, a Thousand Oaks, Calif.-based pharmaceutical company, is set to buy autoimmune drugmaker ChemoCentryx for $3.7 billion in cash.
3. Pfizer to acquire Global Blood Therapeutics for $5.4B
Vaccine-maker Pfizer-BioNTech will acquire Global Blood Therapeutics, which specializes in blood disorder treatments, for $5.4 billion. No final acquisition date has been shared.
4. Shields Health Solutions partners with Billings Clinic
Shields, a Stoughton, Mass.-based specialty pharmacy company, lengthened its 5-yearslong partnership with a Montana clinic.
5. Boston biopharma company’s acquisition completed
Biopharmaceutical company Radius Health, based in Boston, was fully acquired from two investment firms.
6. Aerie Pharmaceuticals to be sold for $770M
Switzerland-based eye care company Alcon plans to buy Aerie Pharmaceuticals, a Durham, N.C.-based business that focuses on eye treatments, for $770 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
